ACROBAT NEWBORN
We put research
into action
MORE THAN 4.000 NEWBORNS WILL PARTICIPATE
ACROBAT joins ground-breaking technological innovation with robust clinical epidemiology to generate quality research and impact
ACROBAT is a 5-year project funded by EDCTP3 to enhance early identification of all-cause sick newborns more likely to develop adverse outcomes with a risk stratification strategy based on a novel point of care test
ACROBAT joins the expertise of multiple Sub-Saharan African institutions for clinical research and technological innovation
ACROBAT takes research to impact African markets and will influence international public health policies
MORE THAN 4.000 NEWBORNS WILL PARTICIPATE
ACROBAT joins ground-breaking technological innovation with robust clinical epidemiology to generate quality research and impact
ACROBAT is a 5-year project funded by EDCTP3 to enhance early identification of all-cause sick newborns more likely to develop adverse outcomes with a risk stratification strategy based on a novel point of care test
ACROBAT joins the expertise of multiple Sub-Saharan African institutions for clinical research and technological innovation
ACROBAT takes research to impact African markets and will influence international public health policies
In 4 African countries
In 4 African countries
THE STUDY
84% of deaths could be prevented with early risk detection
CALENDAR
Clinical and demographic information
Biomarket measurement
Vital sign monitoring
Sample collection
Outcome assessment
WE WORK
With a global and patient-focused
perspective beyond clinical research:
TRANSLATIONAL RESEARCH: FROM LABORATORY TO CLINICAL PRACTICE
TECHNOLOGICAL
INNOVATION
SOCIAL
SCIENCES
EASY-TO-USE MOBILE APP TO ENSURE USEABILITY
HEALTH ECONOMICS & IMPACT ASSESSMENT
regulatory and go-to-market strategies
